-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2020 to Q2 2024.
- PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was $24.7M.
- PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was $34.7M, a 3768% increase year-over-year.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $8.85M, a 314% increase from 2022.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $2.14M, a 1300% increase from 2021.
- PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2021 was $153K, a 113% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)